期刊文献+

金属硫蛋白修饰人脂肪来源间充质干细胞对铅的耐受性研究 被引量:1

Lead tolerance of metallothionein-overexpressed human adipose-derived mesenchymal stem cells
原文传递
导出
摘要 目的构建携带金属硫蛋白(MT)基因的慢病毒载体,验证其在人脂肪来源间充质干细胞(h ADSCs)中的表达及分析其对铅中毒的作用。方法通过慢病毒载体p Lenti-CMV-h ChR 2(E123T-H134R)-EYFP系统,构建MT基因过表达慢病毒载体p Lenti-CMV-MT2A-EYFP,感染h ADSCs,构建携带MT基因的h ADSCs(MT-h ADSCs),应用免疫细胞荧光法检测金属硫蛋白的表达情况。实验分为空白对照组、空载病毒组、重组病毒感染组分析MT-h ADSCs对铅的耐受性,采用MTT法检测各组细胞的存活率。结果成功构建携带金属硫蛋白基因的慢病毒载体p Lenti-CMV-MT2A-EYFP感染h ADSCs,金属硫蛋白获得有效表达,MTT法检测结果显示重组病毒感染组细胞与空白对照组和空载病毒感染组细胞的存活率相比显著提高,具有统计学意义(P<0.05)。结论通过慢病毒载体在h ADSCs中有效表达的金属硫蛋白可提高h ADSCs对铅的耐受性,证实金属硫蛋白能降低重金属铅对细胞的毒性作用。 Objective The lentiviral vector was recombined with metallothionein( MT) gene to identify the MT overexpression in human adipose- derived mesenchymal stem cells( hADSCs) after transfection and then to study the lead tolerance of genetically modified hADSCs with MT( MT- hADSCs). Methods The recombinant plenti- CMV- MT2A-EYFP vector was constructed with pLenti- CMV- hChR 2( E123T-H134R)- EYFP and MT2 A gene for transfecting hADSCs to obtain the MT- hADSCs. The overexpression of MT in hADSCs was identified by immunofluorescence assay. The MTT method was used to assess the cell viability of hADSCs,hADSCs transfected with empty vector,and MT-hADSCs,all of which were treated with lead acetate. Results The recombinant plenti- CMV- MT2A- EYFP was successfully constructed and transfected into hADSCs. The overexpression of MT was positively detected in the MT- hADSCs. The tolerance of MT- hADSCs to lead was significantly higher than the hADSCs and hADSCs transfected with empty vector. Conclusion MT can significantly increase the tolerance of hADSCs to lead,indicating that MT can reduce the cytotoxicity of lead. The experimental results from this study provide more evidences for further study of using MT- hADSCs to treat lead poisoning.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2015年第16期1642-1644,共3页 The Chinese Journal of Clinical Pharmacology
关键词 金属硫蛋白 慢病毒载体 人脂肪来源间充质干细胞 铅中毒 metallothionein lentiviral vector human adipose -derived mesenchymal stem cells lead poisoning
  • 相关文献

参考文献7

  • 1Swindell WR. Metallothionein and the biology of aging[ J]. Ageing Res Rev, 2011, 10:132 - 145.
  • 2Zhang M, Takano T, Liu S, et al. Abiotic stress response in yeast and metal - binding ability of a type 2 metallothionein - like protein (PutMT2) from Puecinellia tenuifloral J]. Mol Biol Rep, 2014, 41 : 5839 - 5849.
  • 3Lira MH, Ong WK, Sugii S. The current landscape of adipose - de- rived stem cells in clinical applications [ J ]. Expert Ret: Mol Med, 2014, 16;e8.
  • 4田霖,孙筱放,刘海波,骆玉梅,陈欣洁,黄东健.人脂肪干细胞的分离培养与生物学特性[J].中国组织工程研究,2012,16(32):5946-5952. 被引量:19
  • 5刘振杰,赵树勇,周静,骆艳婷,郑慧玲,陈维春,熊兴东,徐宁,刘新光.重组金属硫蛋白2A质粒的构建与表达[J].国际检验医学杂志,2012,33(5):513-514. 被引量:2
  • 6方芳,朱平.慢病毒载体的改进为基因治疗带来了新的希望[J].中国实验血液学杂志,2013,21(5):1336-1339. 被引量:10
  • 7Segura MM, Mangion M, Gaillet B, et al. New developments in lentiviral vector design, production and purification[ J]. Expert ()pin Biol Ther, 2013, 13:987-1011.

二级参考文献82

  • 1王逸群,朱平.遗传性铁粒幼细胞贫血研究进展及基因治疗的可能性[J].中国实验血液学杂志,2005,13(3):524-528. 被引量:4
  • 2童坦君,张宗玉.衰老机制及其学说[J].生理科学进展,2007,38(1):14-18. 被引量:48
  • 3姚朝阳,朱文文,牛敬媛,郭伟云,邵强,王天云,杨保胜.金属硫蛋白医学研究进展[J].微量元素与健康研究,2007,24(3):53-55. 被引量:32
  • 4胡绍燕,陈子兴,赵晔,岑建农,谷敏,傅铮铮,何军,顾伟英.WT1基因启动子和增强子在不同细胞株中的转录活性研究[J].中国实验血液学杂志,2007,15(5):1050-1055. 被引量:3
  • 5Hacein-Bey-Abina S,Le Deist F,Carlier F,et al.Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.N Eng J Med,2002;346(16):1185-1193.
  • 6Gaspar HB,Parsley KL,Howe S,et al.Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector.The Lancet,2004 ;364 (9452):2181-2187.
  • 7AA.Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy.J Clin Investig,2007 ; 117 (8):2233-2240.
  • 8Hacein-Bey-Abina S,Garrigue A,Wang GP,et al.Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.J Clin Investig,2008 ; 118 (9):3132-3142.
  • 9McCormack MP,Rabbitts TH.Activation of the T-Cell Oncogene LMO2 after gene therapy for X-Linked Severe Combined Immunodeficiency.N Eng J Med,2004;350(9):913-922.
  • 10Aiuti A,Roncarolo MG.Ten years of gene therapy for primary immune deficiencies.Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program,2009:682-689.

共引文献28

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部